Trial Search Results

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Over 36 Years of Age

To compare pregnancy and live birth rates after untested blastocyst transfer compared to transfer of a single euploid blastocyst after PGT-A among women over age 36 using an intent to treat analysis.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: Preimplantation genetic testing for aneuploidy (PGT-A)

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Women with an indication for IVF between ages 36 0/12-42 11/12 at IVF cycle start
   planning to perform PGT-A

   - Utilization of ICSI or conventional insemination

   - Utilization of ejaculated or testicular sperm

   - Utilization of autologous or donor sperm

   - All COH stimulation protocols

Exclusion criteria:

   - Patients desiring PGT-A for sex selection

   - Utilization of donor oocytes

   - Utilization of gestational carrier

   - PGD/single gene disorders

   - Translocation carriers

Ages Eligible for Study

36 Years - 42 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ruth B Lathi, MD
6504987911
Not Recruiting